Stock listing

TSXV:TLT Theralase Technologies Inc. Stock

Home listing (TSXV) of Theralase Technologies Inc.

Follow Theralase Technologies Inc. into a list and get an email when it puts out news.

Share price · TSXV:TLT

$0.18 CAD -0.02 (-10.0%)

Close on Oct 30, 2026

Past year -12.2% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$0.175 – $0.195 CADOct 30, 2026
Volume
139,043 sharesOct 30, 2026
Market cap
$55.89M CADAt the close on Oct 30, 2026 · price × 310.5M shares outstanding
52-week range
$0.145 – $0.41 CADLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$46,299 CADMedian day 157,346 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Theralase Technologies Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TSXV:TLT · Home$0.18 CAD-0.02 (-10.0%)139,043$0.185$0.195$0.175$0.20Close on Oct 30, 2026
OTC:TLTFF$0.142 USD-0.008 (-5.1%)6,500$0.142$0.142$0.142$0.150Close on Oct 27, 2026
Frankfurt:TTX€0.116 EUR-0.001 (-0.9%)—€0.116€0.116€0.116€0.117Close on Oct 30, 2026
Stuttgart:TTX€0.123 EUR-0.003 (-2.4%)—€0.119€0.123€0.114€0.126Close on Oct 27, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · TSXV:TLT · CAD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.18-0.02-10.0%$0.185$0.195$0.175139,043
$0.200.000.0%$0.205$0.205$0.2023,500
$0.200.000.0%$0.205$0.205$0.2039,890
$0.200.000.0%$0.20$0.21$0.19113,762
$0.20-0.01-4.8%$0.195$0.20$0.19527,859
$0.21-0.01-4.5%$0.22$0.25$0.205512,773
$0.22+0.03+15.8%$0.19$0.23$0.19508,800
$0.190.000.0%$0.19$0.19$0.1926,200
$0.190.000.0%$0.19$0.19$0.1910,000
$0.190.000.0%$0.19$0.19$0.1912,200
$0.190.000.0%$0.19$0.19$0.1843,600
$0.190.000.0%$0.20$0.20$0.1962,100
$0.19+0.01+5.6%$0.19$0.19$0.1868,500
$0.18+0.005+2.9%$0.18$0.19$0.18184,600
$0.1750.000.0%$0.175$0.18$0.175132,102
$0.175-0.005-2.8%$0.175$0.18$0.175216,042
$0.18+0.005+2.9%$0.185$0.185$0.1827,205
$0.175-0.01-5.4%$0.185$0.19$0.175162,540
$0.185+0.01+5.7%$0.185$0.185$0.1871,520
$0.175-0.005-2.8%$0.18$0.18$0.1759,652
$0.180.000.0%$0.18$0.18$0.17176,594
$0.180.000.0%$0.18$0.18$0.175135,050
$0.18+0.005+2.9%$0.18$0.18$0.1831,668
$0.1750.000.0%$0.18$0.18$0.1763,849
$0.1750.000.0%$0.18$0.18$0.1771,411
$0.1750.000.0%$0.18$0.18$0.1776,608
$0.175-0.005-2.8%$0.18$0.18$0.17581,078
$0.18-0.005-2.7%$0.185$0.185$0.18306,004
$0.1850.000.0%$0.19$0.19$0.18178,972
$0.185-0.005-2.6%$0.185$0.19$0.18315,420
$0.19+0.005+2.7%$0.185$0.19$0.18564,657
$0.185+0.005+2.8%$0.185$0.185$0.18514,584
$0.180.000.0%$0.195$0.195$0.18305,125
$0.18-0.01-5.3%$0.185$0.19$0.18184,573
$0.19+0.005+2.7%$0.185$0.19$0.18530,127
$0.185-0.005-2.6%$0.19$0.19$0.18576,919
$0.190.000.0%$0.19$0.19$0.19132,352
$0.19+0.005+2.7%$0.19$0.19$0.197,227
$0.185+0.005+2.8%$0.185$0.185$0.185177,002
$0.18-0.01-5.3%$0.185$0.19$0.18197,631
$0.19+0.005+2.7%$0.18$0.20$0.18278,002
$0.185+0.005+2.8%$0.18$0.185$0.18250,027
$0.18-0.005-2.7%$0.185$0.185$0.18229,049
$0.185+0.005+2.8%$0.18$0.185$0.18248,315
$0.18-0.005-2.7%$0.18$0.185$0.18326,577
$0.185-0.005-2.6%$0.19$0.195$0.18496,508
$0.190.000.0%$0.19$0.19$0.185559,121
$0.19+0.005+2.7%$0.185$0.195$0.185326,571
$0.185-0.005-2.6%$0.195$0.195$0.185344,702
$0.19+0.01+5.6%$0.18$0.20$0.18375,405
$0.180.000.0%$0.18$0.18$0.175289,752
$0.18-0.005-2.7%$0.185$0.185$0.18303,825
$0.1850.000.0%$0.18$0.185$0.18554,474
$0.1850.000.0%$0.185$0.185$0.18801,028
$0.185+0.01+5.7%$0.18$0.19$0.18973,711
$0.175-0.015-7.9%$0.19$0.19$0.1751,071,834
$0.19-0.05-20.8%$0.20$0.205$0.1851,759,937
$0.24-0.025-9.4%$0.26$0.26$0.238285,096
$0.265+0.005+1.9%$0.26$0.265$0.2676,860
$0.260.000.0%$0.265$0.27$0.2617,000
$0.26-0.01-3.7%$0.265$0.265$0.2665,703
$0.27-0.015-5.3%$0.295$0.295$0.27141,513
$0.285+0.005+1.8%$0.28$0.29$0.28152,151
$0.28+0.01+3.7%$0.27$0.29$0.27110,511
Ticker
TSXV:TLT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TSXV
Currency
CAD

What changed lately

Latest news

All Theralase Technologies Inc. news

Financings

  • Private placement of units

    Sep 18, 2026

    Closed: C$3.56M in the latest tranche · C$0.24 a unit · 1 warrant at C$0.32 · Research Capital Corporation

    Dealers: Research Capital Corporation (lead)

    Insiders: An aggregate of 116,250 Units, representing gross proceeds of $27,900, were issued to certain insiders of the Company

    Use of proceeds: GLP toxicology studies for intravenous Rutherrin in cancers and topical Ruvidar for cold sores; working capital and general corporate purposes

    Announced Aug 10, 2026 · Closed Aug 24, 2026 · Closed Aug 28, 2026 · Closed Sep 18, 2026

Read by 6ix AI from the company's releases

Decks

Theralase Technologies Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
34 in the last 12 months · 242 in all · newest Oct 26, 2026 · oldest 2017
Decks
14 decks · latest Oct 22, 2026

Where Theralase Technologies Inc. is listed

ListingExchangeCountryCurrency
TSXV:TLT · Home listing · This pageTSXVCanadaCAD
OTC:TLTFFOTCUnited StatesUSD
Cboe Canada:TLTCboe CanadaCanadaCAD
Lang & Schwarz:A0DLB7Lang & SchwarzGermanyEUR
LS Exchange:A0DLB7LS ExchangeGermanyEUR
Frankfurt:TTXFrankfurtGermanyEUR
Stuttgart:TTXStuttgartGermanyEUR
Dusseldorf:TTXDusseldorfGermanyEUR

Log in to ask 6ix AI your own questions about Theralase Technologies Inc.